Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
The National Pharmaceutical Council (NPC) today released an analysis of seven U.S. value assessment frameworks, comparing and contrasting the strengths and limitations associated with each framework.
In a commentary for Specialty Pharmacy Times, National Pharmaceutical Council (NPC) President and CEO Dan Leonard takes a closer look at what changes are needed to ensure that value assessments can be useful tools for health care decision-making.
Within the last few years, we’ve seen the development of treatments to cure specific types of blindness, cancers and hepatitis C. In coming years, we’re anticipating the Food and Drug Administration approval of medicines to cure sickle cell anemia, hemophilia A and beta thalassemia, among other diseases.